Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Physical Activity Diminishes Symptomatic Decline in Chronic Schizophrenia: A Systematic Review
1 x
$
30.00
View Cart
Checkout
Home
Store
“Physical Activity Diminishes Symptomatic Decline in Chronic Schizophrenia: A Systematic Review” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries
$
30.00
Add to cart
Details
Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity
$
30.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 1, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Treatment of Autism Spectrum Disorder in Children and Adolescents
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 1 – Full Issue Stacked PDF
$
0.00
Add to cart
Details
New Strategies for the Treatment of Indolent Non-Hodgkin’s Lymphomas
$
0.00
Add to cart
Details
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
$
30.00
Add to cart
Details
The Sex Effects Scale: Pilot Validation in a Healthy Population
$
30.00
Add to cart
Details
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
$
30.00
Add to cart
Details
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
$
30.00
Add to cart
Details
Paul E. Holtzheimer III, MD: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression
$
30.00
Add to cart
Details
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
$
30.00
Add to cart
Details
Estudio de validación de la Escala de Salud Personal (ESP) en Lima, Perú
$
0.00
Add to cart
Details
C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions
$
30.00
Add to cart
Details
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
$
30.00
Add to cart
Details
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
Efficacy and Tolerability of Controlled-Release Paroxetine
$
30.00
Add to cart
Details
Previous
1
…
10
11
12
…
44
Next
Page load link
Go to Top
